Abcam and MEDx Expand Strategic Partnership on Claudin 18.2 Diagnosis
UK-based abcam (NASDAQ:ABCM) has announced a licensing agreement with China-headquartered MEDx Translational Medicine Co., Ltd,...
Insight, China's Pharmaceutical Industry
Fineline Insights, Pharma Clarity